Literature DB >> 18707791

The genetics of hyperekplexia: more than startle!

Robert J Harvey1, Maya Topf, Kirsten Harvey, Mark I Rees.   

Abstract

Hyperekplexia is characterised by neonatal hypertonia and an exaggerated startle reflex in response to acoustic or tactile stimuli. Genetic analysis of this disorder has revealed mutations in genes for several postsynaptic proteins involved in glycinergic neurotransmission, including the glycine receptor (GlyR) alpha1 and beta subunits, gephyrin and collybistin. However, new research suggests that mutations in the gene encoding the presynaptic glycine transporter GlyT2 are a second major cause of human hyperekplexia, as well as congenital muscular dystonia type 2 (CMD2) in cattle. These findings raise the intriguing possibility that both presynaptic and postsynaptic causes of disease might also exist in related disorders, such as idiopathic generalised epilepsies, where mutations in inhibitory GABA(A) receptor subunit genes have already been identified.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18707791     DOI: 10.1016/j.tig.2008.06.005

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  79 in total

1.  Behavioral characterization of knockin mice with mutations M287L and Q266I in the glycine receptor α1 subunit.

Authors:  Yuri A Blednov; Jill M Benavidez; Gregg E Homanics; R Adron Harris
Journal:  J Pharmacol Exp Ther       Date:  2011-10-28       Impact factor: 4.030

2.  Incompatibility between a pair of residues from the pre-M1 linker and Cys-loop blocks surface expression of the glycine receptor.

Authors:  Qiang Shan; Joseph W Lynch
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

Review 3.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

4.  Function of hyperekplexia-causing α1R271Q/L glycine receptors is restored by shifting the affected residue out of the allosteric signalling pathway.

Authors:  Qiang Shan; Lu Han; Joseph W Lynch
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease.

Authors:  Wei Xiong; Shao-Rui Chen; Liming He; Kejun Cheng; Yi-Lin Zhao; Hong Chen; De-Pei Li; Gregg E Homanics; John Peever; Kenner C Rice; Ling-gang Wu; Hui-Lin Pan; Li Zhang
Journal:  Nat Neurosci       Date:  2014-01-05       Impact factor: 24.884

Review 6.  What single-channel analysis tells us of the activation mechanism of ligand-gated channels: the case of the glycine receptor.

Authors:  Lucia G Sivilotti
Journal:  J Physiol       Date:  2009-09-21       Impact factor: 5.182

7.  A homozygous ATAD1 mutation impairs postsynaptic AMPA receptor trafficking and causes a lethal encephalopathy.

Authors:  Juliette Piard; George K Essien Umanah; Frederike L Harms; Leire Abalde-Atristain; Daniel Amram; Melissa Chang; Rong Chen; Malik Alawi; Vincenzo Salpietro; Mark I Rees; Seo-Kyung Chung; Henry Houlden; Alain Verloes; Ted M Dawson; Valina L Dawson; Lionel Van Maldergem; Kerstin Kutsche
Journal:  Brain       Date:  2018-03-01       Impact factor: 13.501

Review 8.  Gephyrin: a master regulator of neuronal function?

Authors:  Shiva K Tyagarajan; Jean-Marc Fritschy
Journal:  Nat Rev Neurosci       Date:  2014-03       Impact factor: 34.870

9.  Molecular basis of the dominant negative effect of a glycine transporter 2 mutation associated with hyperekplexia.

Authors:  Esther Arribas-González; Jaime de Juan-Sanz; Carmen Aragón; Beatriz López-Corcuera
Journal:  J Biol Chem       Date:  2014-12-05       Impact factor: 5.157

10.  Localization of glycine receptors in the human forebrain, brainstem, and cervical spinal cord: an immunohistochemical review.

Authors:  Kristin Baer; Henry J Waldvogel; Richard L M Faull; Mark I Rees
Journal:  Front Mol Neurosci       Date:  2009-11-04       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.